The total French market represents €95M. 58% of this amount is generated in private hospitals. Autoexpandable and balloon stents come to 58% of the total market ; (+3.3%, 2019 vs 2018). Boston Scientific and Becton & Dickinson (BD, ex Bard) strongly increased their shares on Drug Eluting Balloon market. To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com #France #Peripheral #Interventional #Vascular #Endovascular #Angioplasty #Market #Shares #Hospital

DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.). To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com #DES #Coronary #Stent #Angioplasty #Heart #Interventional #Cardiology #Inf

In France, the tariffs of the covered, autoexpandable, balloon and drug eluting stents in vascular interventional market will be cut of -8.0% from July 11, 2020 (originally scheduled on 15/05/2020) #Abbott, #Bard #BD, #BBraun, #ABMEDICA, #Andramed, #Bentley, #Medcare, #Medimpulse, #Qualimed, #Vygon, #Medicut, #Biotronik, #Bostonscientific, #Cookmedical, #Cordis, #Hexacath, #Getinge, #Maquet, #Optimed #Terumo #WLGore, #Medtronic, #Endovascular #Peripheral #stent #Vascular #in

#Glass #Y90 #Microsphere #therasphere #Bostonscientific #cancer #liver #Listeensus #LPPR #Reimbursement #Marketaccess #Listing #Cut #Tariff #Addonpayment #France